Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial

Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/27178

Full metadata record

DC Field	Value	Language
dc.contributor.author	Mettananda, C,
dc.contributor.author	Peiris, C.
dc.contributor.author	Abeyrathna, D.
dc.contributor.author	Gunasekera, A.
dc.contributor.author	Egodage, T.
dc.contributor.author	Danthanarayana, C.
dc.contributor.author	Pathmeswaran, A.
dc.contributor.author	Ranasinha, C.
dc.date.accessioned	2024-01-09T09:23:15Z
dc.date.available	2024-01-09T09:23:15Z
dc.date.issued	2023
dc.identifier.citation	Clinical Medicine.2023;23(Suppl 6):66-68	en_US
dc.identifier.issn	1470-2118 (Print)
dc.identifier.issn	1473-4893 (Electronic)
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/27178
dc.description	Indexed in MEDLINE	en_US
dc.description.abstract	No abstract available	en_US
dc.language.iso	en	en_US
dc.publisher	The College	en_US
dc.subject	COVID-19	en_US
dc.title	Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial	en_US
dc.type	Article	en_US
Appears in Collections:	Journal/Magazine Articles

Files in This Item:

There are no files associated with this item.

DSpace JSPUI